Amgen sues Colorado over price-setting prescription drug board

By The Colorado Sun
| March 26, 2024

The state's Prescription Drug Affordability Board is moving forward with possibly setting price limits on Amgen's blockbuster drug Enbrel.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...